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Objectives. Review of burden of congenital transmission of malaria, challenges of preventive measures, and implications for health
system strengthening in sub-Saharan Africa. Methods. Literature from Pubmed (MEDLINE), Biomed central, Google Scholar,
and Cochrane Database were reviewed. Results. The prevalence of congenital malaria in sub-Saharan Africa ranges from 0 to
23%. Diagnosis and existing preventive measures are constantly hindered by weak health systems and sociocultural issues. WHO
strategic framework for prevention: intermittent preventive therapy (IPT), insecticide-treated nets (ITNs), and case management
of malaria illness and anaemia remain highly promising; though, speciﬁc interventions are required to strengthen the health
systems in order to improve the eﬀectiveness of these measures. Conclusion. Congenital malaria remains a public health burden
in sub-Saharan Africa. Overcoming the challenges of the preventive measures hinges on the ability of national governments and
development partners in responding to the weak health systems.
1.Introduction
Malaria remains a signiﬁcant burden in sub-Saharan Africa
asitcontinuestobetheleadingcauseofinfantmorbidityand
mortality in Africa. It is believed that malaria contributes up
toabout25%ofinfantmortalityinNigeria[1].Furthermore,
in areas of Africa with stable transmission, Plasmodium fal-
ciparum infection during pregnancy is estimated to cause as
many as 10,000 maternal deaths each year, 8% to 14% of all
low birth weight babies, and 3% to 8% of all infant deaths
[2]. Thus, malaria burden, if not reduced, poses a threat to
the attainment of the Millennium Development Goals 4 and
6.
Congenital malaria is deﬁned as malaria in a newborn or
infant, transmitted from the mother [3]. Congenital malaria
is generally deﬁned as malaria acquired by the fetus or
newborn directly from the mother, either in utero or during
delivery [4]. It is also deﬁned as the presence of malarial
parasitesintheperipheralsmearofthenewbornfromtwenty
four hours to seven days of life [5]. Malaria is considered
to be congenital in the neonate when asexual parasites are
detected in the peripheral blood within the ﬁrst week of life
[6, 7].
Congenital malaria was thought to be rare in developing
countries [8, 9]. This might be due to a number of reasons.
Firstly, the protective eﬀect of the foetal haemoglobin (HbF)
in a newborn is expected to exert its inﬂuence during the
immediate neonatal period [10, 11]. Secondly, local health
facilities in resource-limited settings often lack the capacity
to diagnose malarial infection [12–14]. Thirdly, the clinical
signs of neonatal malaria may be indistinguishable from
those of neonatal sepsis [15]. Thus, congenital malaria might
pass unnoticed, and this might be responsible for its under-
reporting. Therefore, the aim of this paper was to highlight
the prevalence and burden of congenital malaria in sub-
Saharan Africa as well as the challenges of its diagnosis and2 Journal of Tropical Medicine
prevention;theﬁndingswereusedtosuggestmeasuresaimed
at strengthening health systems and reducing the burden of
congenital malaria in the population.
2. Methods
Literature providing information on the prevalence, burden,
diagnosis, prevention, and control of congenital malaria,
published between 2000 and 2010 was reviewed. Search
terms included “congenital,” “Malaria,” “burden,” “diag-
nosis,” “prevention”, “control,” and “sub-Saharan Africa.”
These literatures were accessed from Pubmed (MEDLINE),
Biomed central, Google Scholar, and Cochrane Database of
Systematic Reviews. Searches were also supplemented with
recommendationsfromoutsideexperts,reviewsofbibliogra-
phies of other relevant articles, and systematic reviews.
3. Results
3.1. Prevalence of Congenital Malaria in Sub-Saharan African
Countries. Congenital malaria is rare in developed countries
such as the United States of America, where only three
infants out of 4.1 million live births were reported to have
congenital malaria [16]. The situation is however diﬀerent
and widely varied in sub-Saharan African countries. To this
end, recent reports have suggested that congenital malaria
is not as rare in developing countries as previously thought
[17]. For example, in a survey covering seven sites in sub-
SaharanAfrica,Fischershowedameanprevalencerateof7%
for congenital malaria (range 0–23%) [9].
Furthermore, while a study in Kenya reported a preva-
lence of malarial parasitaemia in <0.5% of neonatal admis-
sions [18], high prevalence of congenital and neonatal par-
asitaemia (>20%) was reported in Uganda and Zambia [19].
A study done in Ghana revealed an incidence of 13.6% con-
genitalmalariainfections[20].InNigeria,congenitalmalaria
was documented in 13.6% of babies at delivery [21]. In
another multicentre study in Nigeria, the overall incidence
of congenital malaria was 5.1% (range 1.1%–11.5%) [6]. In
addition, Runsewe-Abiodun et al. have reported a congenital
malaria prevalence rate of 17.4% among sick neonates in a
tertiary hospital in southwestern Nigeria [17].
3.2. Burden of Congenital Malaria in Sub-Saharan Africa. It
is estimated that placental malaria is responsible for 35% of
preventable low birth weight in developing countries [22]. It
is also associated with intrauterine growth restriction, pre-
maturity due to preterm labour and intrauterine foetal death
[23]. Malaria in pregnancy is reported to cause between
75,000 and 200,000 infant deaths each year in sub-Saharan
Africa [22].
3.3. Challenges in Detection of Congenital Malaria. The de-
tection of malaria parasites in the infant’s blood is essential
for diagnosis, although blood smears can be negative if there
are low parasite counts (50parasites/µL blood) [23]. Pengsaa
suggested that three repeated blood smears over 48 hours
should be reported negative before excluding the diagnosis
[19]. The capacity to conduct blood test for the diagnosis of
congenitalmalariaishoweverlimitedinsub-SaharanAfrican
countries. This is because studies have shown a persistent
lack of capacity to conduct quality malaria diagnostic tests
by local health facilities [12–14].
Cord malaria can also be detected by polymerase chain
reaction(PCR).TheuseofPCRhassuggestedthatcongenital
malaria may be more frequent, although it is unclear if a
positivePCRrepresentsanactiveinfection[4].Though,PCR
is a more sensitive and accurate diagnostic technique than
blood smear microscopy, its use is however very limited in
developing countries as it is expensive and requires a spe-
cialized laboratory [4].
Apart from the laboratory constraints, low antenatal care
attendance and skilled delivery rates in African countries will
also aﬀect detection and prevention of congenital malaria.
Antenatal care utilization in the developing countries is
about 65%; this is low compared to that of the developed
countries, which is 97% [24]. The implication is that in
about two thirds of pregnant women in sub-Saharan Africa,
opportunities for early recognition and prompt treatment of
malaria infection are missed.
3.4. Challenges in the Clinical Diagnosis. The clinical diag-
nosis of congenital malaria usually poses a challenge. This
is because its clinical ﬁndings may be indistinguishable
from those of neonatal sepsis [15]; hence, the condition is
either detected late or not even suspected unless neonates
are speciﬁcally screened for it. Furthermore, as with many
congenital infections, the new born child can manifest with
fever, irritability, feeding problems, hepatosplenomegaly,
anemia, jaundice, and low birth weight [25].
Thus, the clinical distinction from other congenital
infections rests primarily on maternal history of exposure
to malaria and absence of a skin rash [23]. A study done
in Calabar, Nigeria, reported that 35% of newborns with
clinicalsignsofneonatalsepsiswerefoundtohavecongenital
malaria [26]. Fever was the most common feature reported
by studies in Kenya and Nigeria among others, which
include refusal to feed or poor feeding, irritability, anaemia,
hepatosplenomegaly, and jaundice [6].
3.5. Challenges in Prevention of Congenital Malaria in Sub-
Saharan African Countries. Prevention of any disease con-
dition requires the availability of methods for prediction of
those at high risk of the disorder. If there were tests which
are adequately sensitive for detecting placenta malaria in
the antenatal period, it would have helped in assessing the
eﬃcacy of antimalarial drug during pregnancy and iden-
tifyingtheinfantsatriskofcongenitalmalaria[27].However,
there are no tests which are adequately sensitive for detecting
placental malaria; hence, the diﬃculty in identifying those at
high risk of this condition.
Therefore, malaria preventive measures in pregnancy
still remain as priority interventions required to protect the
foetus and the newborn against the adverse eﬀects of con-
genital malaria. The World Health Organization (WHO)
has recommended a three-pronged strategic framework inJournal of Tropical Medicine 3
areas of high or moderate (stable) malaria transmission of
sub-Saharan Africa: intermittent preventive therapy (IPT),
insecticide-treated nets (ITNs), and case management of
malaria illness and anaemia [28].
3.5.1. Intermittent Preventive Therapy (IPT). Intermittent
preventive therapy (IPT), also known as chemoprophylaxis
for pregnant women, especially those in their ﬁrst pregnan-
cies, has been widely used in sub-Saharan Africa. In line with
WHO recommendation, most national guidelines stipulate
that all pregnant women should receive at least two doses
of IPT given as sulphadoxine-pyrimethamine (SP) combi-
nation after quickening as part of preventive treatments
at antenatal care [28]. Evidence abound that this measure
has recorded successes. For example, researchers in Kenya
and Malawi have shown that intermittent preventive therapy
with sulphadoxine-pyrimethamine signiﬁcantly reduces the
prevalence of maternal anaemia and placental parasitaemia,
and the incidence of low birth weight [29–32]. Furthermore,
sulphadoxine-pyrimethamine has been found to be safe
in pregnancy and eﬃcacious in reproductive-age women;
hence, its strong acceptance and coverage levels of greater
than 80% for the ﬁrst dose [29].
Despite the beneﬁcial impact of sulphadoxine-pyrxim-
ethamine on maternal and infant health, its utilization is
threatened by weak health systems and sociocultural issues
in sub-Saharan Africa. Studies have shown that a substantial
proportion (20% to 80%) of pregnant women in this setting
make their ﬁrst antenatal visit in their third trimester
[33–35]. Furthermore, unbooked pregnancies are common
[36, 37], and antenatal care utilization rate (i.e., antenatal
care clinic attendance of at least once during most recent
pregnancy) varies from 60% to 90% [1, 38, 39]. These
ﬁndings could be partly attributed to low quality of service
and sociocultural reasons. While evidence abound on the
persistent declining quality of antenatal services provided to
pregnant women [33, 35, 40], other researchers have found
that perceived quality of service was the most important
factor which inﬂuenced the choice of facility for obstetric
care[41];similarly,aperceivedlackofqualityintheantenatal
care was associated with a late ﬁrst antenatal visit in Kenya
[35].
Within the sociocultural context, it is thought that non-
initiation of care in the ﬁrst trimester seems to be a wide-
spread cultural practice in sub-Saharan Africa. In rural
Gambia, women do not usually “announce” pregnancy
but wait for other family members to discover it, thereby
presenting for care well into the third trimester [42]. While
further qualitative research is required to explore the extent
to which late ﬁrst antenatal visit is aﬀected by cultural
practices, the implication of the ﬁndings is that a substantial
proportion of pregnant women always remains unprotected
against malaria infection because of missed opportunity of
treatment in the second trimester. This therefore exposes
fetuses of such unprotected women to placental malaria and
its adverse eﬀects, thereby contributing to the challenges
militating against prevention of congenital malaria. This
situation is further worsened by the practice of partial pre-
ventive treatments, including sulphadoxine-pyrimethamine
(SP) therapy provided by health workers at antenatal care
service [33, 35, 43].
3.5.2. Insecticide-Treated Nets (ITNs). Randomized control
trials in sub-Saharan Africa have consistently shown the
eﬀectiveness of insecticide-treated nets (ITNs) in the pre-
vention of malaria in pregnancy. Studies in Ghana and
Kenyahavedocumentedreducedplacentalmalaria,lowbirth
weight, and fetal loss resulting from use of ITNs [44].
Though the use of insecticide-treated nets (ITNs) is re-
portedly considered as the most cost-eﬀective method of
malaria prevention in highly endemic areas, there have
always been some concerns about the preventive strategy
in sub-Saharan Africa; these concerns include access, cost,
retreatment, and gaps between ownership and use of ITN.
Access to ITNs by vulnerable populations including
pregnant women continues to increase due to the eﬀorts of
national governments and supporting development agencies
throughmultipleapproachessuchasstand-alonecampaigns,
health facilities, and antenatal clinic [1, 38]. Access is also
enhanced by free distribution and sales of ITNs at subsidized
costorthroughdiscountedvouchersystems[1,38,45],while
the introduction of long-lasting insecticidal nets (LLINs) has
reduced the burden of frequent retreatments.
Despite these eﬀorts, recent ﬁndings revealed low utiliza-
tion of ITNs among pregnant women. Though increasing
trends in ownership and use of ITNs by households were
reported in national demographic surveys, the reports
indicated that 5% to 57% of pregnant women aged 15–49
years slept under an ITN the past night. Furthermore, gaps
between ownership and use of an ITN continue to exist as
about 50% or less of pregnant women aged 15–49 years in
households with an ITN slept under the net the past night
[1, 38, 46, 47].
3.5.3. Case Management of Malaria Illness. Supporting and
promoting access to correct, aﬀordable, and appropriate
treatment within 24 hours of the onset of symptoms
of malaria is the third essential component of malaria
prevention and control during pregnancy in malarious
endemic countries of sub-Saharan Africa [28]. The World
Health Organization (WHO) had recommended chloro-
quine(CQ)inchloroquine-sensitiveareasandsulphadoxine-
pyrimethamine (SP) in areas with CQ resistance for treat-
ment of uncomplicated malaria in pregnancy. Quinine is
another alternative in areas where both CQ and SP are not
eﬀective [28].
However, prompt and eﬀective case management of
malaria illness is hinged on early and correct diagnosis of
the condition. As noted above, this is seriously hindered by
lackofcapacitytoconductqualitymalariadiagnostictestsby
local health facilities in sub-Saharan African countries [12–
14].Whilethissituationmighthavejustiﬁedthepresumptive
treatment of fever with antimalarials (i.e., treating all febrile
episodes suspected of malaria with a full therapeutic dose
of antimalarials), such practice might have led to a reduced4 Journal of Tropical Medicine
susceptibility of parasites to the commonly used antimalarial
drugs in these settings.
3.6. Recommendations
3.6.1. Health System Strengthening. The World Health Orga-
nization (WHO) recently recommended prompt parasito-
logic conﬁrmation by microscopy or alternatively by rapid
diagnostic tests (RDTs) in all patients suspected of malaria
before treatment is commenced unless parasitological diag-
nosis is not accessible [48]. Findings from the previous
review revealed that many peripheral health facilities in
resource-poor settings of sub-Saharan Africa lacked the
capacity to conduct quality parasitological diagnosis of
malaria by microscopy; this is because the procedure is
labour-intensive requiring trained staﬀ and quality equip-
ment [49, 50].
On the other hand, malaria rapid diagnostic testing
(RDT) has been found useful as an attractive alternative to
routine microscopy with good sensitivity and speciﬁcity pro-
ﬁles [48, 51]. In addition, RDTs have the potential to be cost-
eﬀective,require no capital investment or electricity, are sim-
pletoperform,andareeasytointerpret[51,52].Ifappropri-
ately introduced and implemented, it also has been shown to
have the potential of improving drug-prescribing behaviour
of health workers [53], thereby reducing overtreatment of
malaria and the problem of drug resistance.
From the foregoing, utilization of RDTs in resource-poor
settings would seem to be an appropriate technology as it has
the potential of improving the quality of malaria diagnosis
and treatment services provided to all cases of malaria,
including pregnant women and newborns. Therefore, it
is suggested that national governments and development
partners in sub-Saharan Africa should support widespread
use of rapid diagnostic tests (RDTs) for malaria diagnosis.
The capacity of local health facilities providing maternal
and child health services should be strengthened with the
provision of adequate supplies of equipment and con-
sumables required to provide the diagnostic services. In
addition, targeted trainings and supportive supervision of
localhealthstaﬀarehighlydesirableinordertomeetupwith
the challenges of newly-assigned task.
In order to increase uptake of IPTs and facilitate prompt
diagnosis and treatment of malaria in pregnancy, national
governments and development partners in sub-Saharan
African countries should also consider improving the poor
maternal health service indicators—nonbooking, late ante-
natal visits and low antenatal service rate—as an essential
tasktobeconcertedlypursued.Toachievethistask,strategies
aimed at improving maternal health service should be
implemented. For example, proven-speciﬁc interventions
such as the World Health Organization (WHO) training
on Life Saving Skills [54]a r es u g g e s t e df o ru s eo fm a t e r n a l
health service managers in addressing the weak health
systems. Periodic trainings conducted for local health staﬀ
can help address and strengthen health systems, particularly
if targeted at previously reported areas of deﬁciency such
as declining quality of maternal health service, poor record
keeping practices of health workers, and poor utilization of
intrapartum monitoring tools such as a partograph [33, 34,
55].
In addition, health staﬀs’ familiarization and adherence
to WHO guidelines on provision of eﬀective, eﬃcient, safe,
and culturally appropriate services to pregnant women and
newborn under the Integrated Management of Pregnancy
and Childbirth (IMPAC) would assist to ensure best prac-
tices [56]. It is expected that these eﬀorts would improve
utilization of maternal health services, increase IPT uptake,
enhance prompt diagnosis and treatment of malaria in
pregnancy, and consequently prevent congenital malaria.
On a long term basis, strategies which would bring
about over 80% antenatal service utilization rate should be
pursuedvigorously.Therefore,itissuggestedthatredirecting
and repackaging health education and service content of
antenatal care service using a social marketing approach
acceptable within the sociocultural context would be found
useful. Therefore, placing the antenatal care service content
and its beneﬁts on public agenda through diﬀerent media
and matrices may be helpful in the study setting as opposed
to the current practice of restricting information to women
who make antenatal visits.
Despite male economic dominance and decision mak-
ing power in developing countries, their involvement in
reproductive health issues is reportedly low [57]. However,
studieshadshownthatmaleinvolvement wouldsigniﬁcantly
improve indicators of maternal health service utilization,
[58] and, therefore, it could also improve uptake of IPTs
and case management of malaria in pregnancy. Hence, it
is recommended that father’s roles in maternal health be
deﬁned, packaged, and incorporated in the antenatal care
service messages meant for dissemination to the public.
With regard to closing the gap between ownership and
use of an ITN, a carefully designed qualitative research may
be useful in eliciting the factors responsible or reasons for
not sleeping under an ITN despite its availability in the
household. While it is suggested that national governments
and development partners should not relent on their eﬀorts
in making ITNs universally accessible to pregnant women
either free of charge or at a subsidized price, experiences of
other researchers on factors which promote or inhibit ITN
usage may be found useful in packaging educational mes-
sages aimed at promoting its usage. ITN usage promoting
factors such as high perception on the seriousness of malaria
and its eﬀect on pregnant women and children, high per-
ceived beneﬁt of ITNs in protecting children and pregnant
women against malaria, and high awareness of the preven-
tionofmalariaasabetterandcheaperoptioncomparedwith
treatment should be intensiﬁed. Whereas inhibitory factors
such as fear of the chemical that is used to treat nets and
unsupportive spouses should be demystiﬁed [59].
4. Conclusion
Evidence abound that congenital malaria constitutes a public
health burden in sub-Saharan Africa. However, eﬀorts of
the national governments and development partners atJournal of Tropical Medicine 5
instituting the recommended cost-eﬀective interventions
are continuously thwarted by challenges brought about by
weak health systems and sociocultural factors among others,
thereby, militating against the progress towards attainment
of Millennium Development Goal (MDG) 6 (Indicator 22,
Target 8). Health system strengthening and appropriate
public health promoting and educating messages delivered
through a social marketing approach may be found useful in
putting back on track the race towards 2015 with respect to
attainment of MDG 6.
References
[1] National Population Commission [Nigeria] and ICF Macro,
Nigeria Demographic and Health Survey 2008, National Popu-
lation Commission and ICF Macro, Abuja, Nigeria, 2009.
[2] RollBackMalaria,MalariainPregnancy,http://www.rbm.who
.int/cmc upload/0/000/015/369/RBMInfosheet 4.htm.
[3] Centers for Disease Control and Prevention, http://www.cdc
.gov/malaria/glossary.html.
[4] O. Coll, C. Menendez, F. Botet et al., “Treatment and pre-
vention of malaria in pregnancy and Newborn,” Journal of
Perinatal Medicine, vol. 36, pp. 15–29, 2008.
[5] O. Basipinar, Z. Bayraktaroglu, T. Karsligil, A. Bavram, and
Y. Coskun, “A rare cause of anemia and thrombocytopenia
in a newborn: congenital malaria,” The Turkish Journal of Pe-
diatrics, vol. 48, pp. 63–65, 2006.
[6] C. Falade, O. Mokuolu, H. Okafor et al., “Epidemiology of
congenital malaria in Nigeria: a multi-centre study,” Tropical
Medicine and International Health, vol. 12, no. 11, pp. 1279–
1287, 2007.
[7] Ghana Health Service, “Guidelines for malaria in pregnancy,”
http://www.ghanahealthservice.org/.
[8] A. A. Orogadeav, C. Falade, H. U. Okafor et al., “Clinical and
laboratory features of congenital malaria in Nigeria,” Journal
of Pediatric Infectious Diseases, vol. 3, pp. 181–187, 2008.
[9] P. R. Fischer, “Congenital malaria: an African survey,” Clinical
Pediatrics, vol. 36, no. 7, pp. 411–413, 1997.
[10] H. L. Shear, L. Grinberg, J. Gilman et al., “Transgenic mice ex-
pressing human fetal globin are protected from malaria by a
novel mechanism,” Blood, vol. 92, no. 7, pp. 2520–2526, 1998.
[11] C. Shulman and E. Dorman, “Clinical features of malaria in
pregnancy,” in Essential Malariology, D. A. Warrell and H. M.
Gilles, Eds., p. 223, BookPower Formerly ELST, London, UK,
4th edition, 2002.
[12] P. A. Phillips-Howard, K. A. Wannemuehler, F. O. Ter Kuile et
al., “Diagnostic and prescribing practices in peripheral health
facilities in rural western Kenya,” American Journal of Tropical
Medicine and Hygiene, vol. 68, supplement 4, pp. 44–49, 2003.
[13] B. Hailegiorgis, S. Girma, Z. Melaku et al., “Laboratory ma-
laria diagnostic capacity in health facilities in ﬁve adminis-
trative zones of Oromia Regional State, Ethiopia,” Tropical
Medicine and International Health, vol. 15, no. 12, pp. 1449–
1457, 2010.
[14] D. Ishengoma, Y. Derua, R. Rwegoshora et al., “The perform-
anceofhealthlaboratoriesandthequalityofmalariadiagnosis
in six districts of Tanzania,” Annals of Tropical Medicine and
Parasitology, vol. 104, no. 2, pp. 123–135, 2010.
[15] W. I. Olanrewaju, “Malaria in the neonate: report of 2 cases,”
West African Journal of Medicine, vol. 18, no. 2, pp. 139–140,
1999.
[16] C.R.Lesko,P.M.Arguin,andR.D.Newman,“Congenitalma-
laria in the United States: a review of cases from 1966 to 2005,”
Archives of Pediatrics and Adolescent Medicine, vol. 161, no. 11,
pp. 1062–1067, 2007.
[17] I. T. Runsewe-Abiodun, O. B. Ogunfowora, and B. M. Fetuga,
“Neonatal malaria in Nigeria— a 2 year review,” BMC
Pediatrics, vol. 6, article 19, 2006.
[18] M. K. Mwaniki, A. W. Talbert, F. N. Mturi et al., “Congenital
and neonatal malaria in a rural Kenyan district hospital: an
eight-year analysis,” Malaria Journal, vol. 9, no. 1, article 313,
2010.
[19] K. Pengsaa, “Congenital malaria in Thailand,” Annals of Trop-
ical Paediatrics, vol. 27, no. 2, pp. 133–139, 2007.
[20] G. Wagner, K. Koram, D. McGuinness, S. Bennett, F. Nkru-
mah, and E. Riley, “High incidence of asymptomatic malara
infections in a birth cohort of children less than one year
of age in Ghana, detected by multicopy gene polymerase
chainreaction,”TheAmericanJournalofTropicalMedicineand
Hygiene, vol. 59, no. 1, pp. 115–123, 1998.
[21] F. Lesi, M. Mukhtar, E. Iroha, and M. Egri-Okwaji, “Clinical
presentation of congenital malaria at the Lagos University
Teaching Hospital,” The Nigerian Journal of Clinical Practice,
vol. 13, no. 2, pp. 134–138, 2010.
[22] R. W. Steketee, B. L. Nahlen, M. E. Parise, and C. Menendez,
“The burden of malaria in pregnancy in malaria-endemic
areas,” The American Journal of Tropical Medicine and Hygiene,
vol. 64, supplement 1-2, pp. 28–35, 2001.
[23] B. J. Brabin, “Congenital malaria— a recurrent problem,” An-
nals of Tropical Paediatrics, vol. 27, no. 2, pp. 95–98, 2007.
[24] Maternal Mortality in 2005, World Health Organization,
Geneva, Switzerland, 2007.
[25] C. Menendez, “Malaria during pregnancy: a priority area of
malaria research and control,” Parasitology Today, vol. 11, no.
5, pp. 178–183, 1995.
[ 2 6 ]A .D .E k a n e m ,M .U .A n a h ,a n dJ .J .U d o ,“ T h ep r e v a l e n c eo f
congenital malaria among neonates with suspected sepsis in
Calabar, Nigeria,” Tropical Doctor, vol. 38, no. 2, pp. 73–76,
2008.
[27] H. Guyatt and R. Snow, “Malaria in pregnancy as an indirect
cause of infant mortality in sub-SaharanAfrica,” Transactions
of the Royal Society of Tropical Medicine and Hygiene, vol. 95,
no. 6, pp. 569–576, 2001.
[28] World Health Organization, “A strategic framework for ma-
laria prevention and control during pregnancy in the African
region,” WHO Regional Oﬃce for Africa, Brazzaville, The Re-
public of the Congo, AFR/MAL/04/01, 2004.
[29] F. Verhoeﬀ, B. Brabin, L. Chimsuku, P. Kazembe, W. Russell,
andR.Broadhead,“Anevaluationoftheeﬀectsofintermittent
sulfadoxine-pyrimethamine treatment in pregnancy on par-
asite clearance and risk of low birthweight in rural Malawi,”
Annals of Tropical Medicine and Parasitology,v o l .9 2 ,n o .2 ,p p .
141–150, 1998.
[30] L. J. Schultz, R. W. Steketee, A. Macheso, P. Kazembe, L. Chit-
sulo, and J. J. Wirima, “The eﬃcacy of antimalarial regimens
containing sulfadoxine-pyrimethamine and/or chloroquine in
preventing peripheral and placental Plasmodium falciparum
infection among pregnant women in Malawi,” The American
Journal of Tropical Medicine and Hygiene,v o l .5 1 ,n o .5 ,p p .
515–522, 1994.
[ 3 1 ]M .E .P a r i s e ,J .G .A y i s i ,B .L .N a h l e ne ta l . ,“ E ﬃcacy of sul-
fadoxine-pyrimethamine for prevention of placental malaria
in an area of Kenya with a high prevalence of malaria and
human immunodeﬁciency virus infection,” The American6 Journal of Tropical Medicine
Journal of Tropical Medicine and Hygiene,v o l .5 9 ,n o .5 ,p p .
813–822, 1998.
[32] C. Shulman, E. Dorman, F. Cutts et al., “Intermittent sul-
phadoxine-pyrimethamine to prevent severe anaemia sec-
ondary to malaria in pregnancy: a randomised placebo-
controlled trial,” The Lancet, vol. 353, no. 9153, pp. 632–636,
1999.
[33] K. Osungbade, S. Oginni, and A. Olumide, “Content of an-
tenatal care services in secondary health care facilities in
Nigeria: implication for quality of maternal health care,” In-




Women International, vol. 32, no. 5, pp. 441–452, 2011.
[35] A. van Eijk, H. Bles, F. Odhiambo et al., “Use of antenatal ser-
vices and delivery care among women in rural Western Kenya:
a community based survey,” Reproductive Health, vol. 3, article
2, 2006.
[ 3 6 ]B .C h i g b u ,S .O n w e r e ,C .I .K a m a n u ,C .A l u k a ,O .O k o r o ,
and E. Adibe, “Pregnancy outcome in booked and unbooked
mothers in South Eastern Nigeria,” East African Medical
Journal, vol. 86, no. 6, pp. 267–271, 2009.
[37] A.T .Owolabi,A.O .Fatusi,O .K uti,A.A deyemi,S.O .Fatur oti,
and P. O. Obiajuwa, “Maternal complications and perinatal
outcomes in booked and unbooked Nigerian mothers,” Sin-
gapore Medical Journal, vol. 49, no. 7, pp. 526–531, 2008.
[38] Ghana Statistical Service, Ghana Health Service, and ICF
Macro, Ghana Demographic and Health Survey 2008, GSS,
GHS, and ICF Macro, Accra, Ghana, 2009.
[39] S. Babalola and A. Fatusi, “Determinants of use of maternal
health services in Nigeria—looking beyond individual and
household factors,” BMC Pregnancy and Childbirth, vol. 9,
article 1471, p. 43, 2009.
[40] A. Sagay, C. Ekwempu, M. Kabiru, P. Daru, and A. Aisien,
“Audit of antenatal services in primary healthcare centres in
Jos, Nigeria,” Tropical Journal of Obstetrics & Gynaecology, vol.
22, no. 2, pp. 147–151.
[41] C. Iyaniwura and Q. Yussuf, “Utilization of antenatal care and
delivery services in Sagamu, South Western Nigeria,” African
Journal of Reproductive Health, vol. 13, no. 3, pp. 111–122,
2009.
[42] M. L. Telfer, J. T. Rowley, and G. E. Walraven, “Experiences of
mothers with antenatal, delivery and postpartum care in rural
Gambia,” AfricanJournal of Reproductive Health,v o l .6 ,n o .1 ,
pp. 74–83, 2002.
[43] National Population Commission (Nigeria) and ORC Macro,
Nigeria Demographic and Health Survey 2003, National Popu-
lationCommission(Nigeria)andORCMacro,Calverton,Md,
USA, 2004.
[44] C. Gamble, J. P. Ekwaru, and F. O. ter Kuile, “Insecticide-
treated nets for preventing malaria in pregnancy,” Cochrane
Database of Systematic Reviews, no. 2, p. CD003755, 2006.
[45] A. Tami, J. Mbati, R. Nathan, H. Mponda, C. Lengeler, and J.
Schellenberg, “Use and misuse of a discount voucher scheme
as a subsidy for insecticide-treated nets for malaria control in
southern Tanzania,” Health Policy and Planning, vol. 21, no. 1,
pp. 1–9, 2005.
[46] Kenya National Bureau of Statistics and ICF Macro, Kenya
Demographic and Health Survey 2008–2009, KNBS and ICF
Macro, Calverton, Md, USA, 2010.
[47] Tanzania National Bureau of Statistics and ICF Macro, Tan-
zania Demographic and Health Survey 2009–2010,K N B Sa n d
ICF Macro, Calverton, Md, USA, 2010.
[48] World Health Organization, World Malaria Report 2009, 2009.
[49] P.Bloland,S.Kachur,andH.Williams,“Trendsinantimalarial
drug deployment in sub-Saharan Africa,” Journal of Experi-
mental Biology, vol. 206, no. 21, pp. 3761–3769, 2003.
[50] F. Moerman, C. Lengeler, J. Chimumbwa et al., “The contri-
bution of the health-care service to a sound and sustainable
malaria-control policy,” The Lancet Infectious Diseases, vol. 3,
no. 2, pp. 99–102, 2003.
[51] C. Wongsrichanalai, M. J. Barcus, S. Muth, A. Sutamihardja,
and W. H. Wernsdorfer, “A review of malaria diagnostic tools:
microscopy and rapid diagnostic test (RDT),” The American
Journal of Tropical Medicine and Hygiene,v o l .7 7 ,n o .6 ,p p .
119–127, 2007.
[52] S. Shillcutt, C. Morel, C. Goodman et al., “Cost-eﬀectiveness
of malaria diagnostic methods in sub-Saharan Africa in an
era of combination therapy,” Bulletin of the World Health
Organization, vol. 86, no. 2, pp. 101–110, 2008.
[53] G. Bastiaens, E. Schaftenaar, A. Ndaro et al., “Malaria di-
agnostictestingandtreatmentpracticesinthreediﬀerentPlas-
modium falciparum transmission settings in Tanzania: before
and after a government policy change,” Malaria Journal, vol.
10, p. 76, 2011.
[54] World Health Organization, “Making pregnancy safer: the
critical role of the skilled attendant. A joint statement by
WHO, ICM and FIGO,” Department of Reproductive Health
and Research, WHO, 2004 http://www.who.int/reproductive
-health/publications/2004/skilled attendant.pdf.
[55] O. Oladapo, O. Daniel, and A. Olatunji, “Knowledge and
use of the partograph among health care personnel at the
peripheral maternity centres in Nigeria,” Journal of Obstetrics
and Gynaecology, vol. 26, no. 6, pp. 538–541, 2006.
[56] WorldHealthOrganization,Pregnancy,Childbirth,Postpartum
and Newborn Care: A Guide for Essential Practice (Integrated
Management of Pregnancy and Childbirth), World Health
Organization,2ndedition,2006,http://www.who.int/making
pregnancy safer/publications/PCPNC 2006 03b.pdf.
[57] Z. Iliyasu, I. S. Abubakar, H. S. Galadanci, and M. H. Aliyu,
“Birth preparedness, complication readiness and fathers’ par-
ticipation in maternity care in a northern Nigerian commu-
nity,” African Journal of Reproductive Health,v o l .1 4 ,n o .1 ,p p .
21–32, 2010.
[58] L. Martin, M. McNamara, A. Milot, T. Halle, and E. C. Hair,
“The eﬀects of father involvement during pregnancy on re-
ceipt of prenatal care and maternal smoking,” Maternal and
Child Health Journal, vol. 11, no. 6, pp. 595–602, 2007.
[59] U. M. Chukwuocha, I. N. Dozie, C. O. Onwuliri et al.,
“Perceptions on the use of insecticide treated nets in parts
of the Imo River Basin, Nigeria: implications for preventing
malaria in pregnancy,” African Journal of Reproductive Health,
vol. 14, no. 1, pp. 117–128, 2010.